DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $103,000 | -89.4% | 16,924 | -89.9% | 0.01% | -87.0% |
Q1 2019 | $975,000 | +235.1% | 167,889 | +1018.1% | 0.07% | +213.6% |
Q3 2018 | $291,000 | -69.9% | 15,015 | -60.3% | 0.02% | -67.2% |
Q2 2018 | $966,000 | +189.2% | 37,794 | +126.8% | 0.07% | +81.1% |
Q4 2017 | $334,000 | +85.6% | 16,661 | +36.8% | 0.04% | -24.5% |
Q2 2017 | $180,000 | -61.6% | 12,177 | -67.3% | 0.05% | -33.8% |
Q4 2016 | $469,000 | +34.0% | 37,238 | +197.7% | 0.07% | -5.1% |
Q3 2016 | $350,000 | -32.3% | 12,509 | -17.2% | 0.08% | +69.6% |
Q4 2015 | $517,000 | +84.6% | 15,109 | +139.8% | 0.05% | +48.4% |
Q2 2015 | $280,000 | – | 6,300 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |